Poland· PL-100109461
Moklar
A moclobemide product containing moclobemidum, registered in Poland by neuraxpharm Arzneimittel GmbH. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Moclobemide is registered in 12 of 19 countries.
Countries holding a registration under ATC N06AG02 (moclobemide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Moclobemide · ATC N06AG02
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of moclobemide costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.54 in France to $1.38 in Switzerland — a ×2.6 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Moclobemide · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.38
- FR France$0.54
The record
At a glance
URPL (Poland)- Active substance
- Moclobemidum
- Manufacturer
- neuraxpharm Arzneimittel GmbH
- Country
- Poland (PL)
- ATC code
- N06AG02
- ATC class
- Moclobemide
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990953714
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
25 interactions on record for moclobemide.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Moclobemide · interactions on record
25 records
25 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Moclobemide in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAurorixViatris Oy
- SwedenAurorix 150 mg Filmdragerad tablettViatris AB
- CzechiaAURORIXVIATRIS HEALTHCARE LIMITED, Dublin
- BelgiumMoclobemide Mylan 150 mgViatris GX
- SwitzerlandAurorix 150
- NorwayAurorix2care4 ApS
- FranceMOCLAMINE 150 mg, comprimé pelliculé sécableBIOCODEX
- IrelandManerix 150 mg Film-coated TabletsViatris Healthcare Limited
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Aurorix
- Belgium · Moclobemide Sandoz
- Czechia · Aurorix
- Germany · Aurorix, Moclobemid 1 A Pharma
- Spain · Manerix
- Finland · Aurorix
- France · Moclamine
- United Kingdom (Northern Ireland) · Manerix, Moclobemide
- Hungary · Aurorix
- Ireland · Manerix
- Netherlands · Moclobemide Sandoz
- Norway · Aurorix
- Portugal · Aurorix, Zorix
- Sweden · Aurorix
- Slovenia · Aurorix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b7cef24c-9bed-4f1e-9f2f-6c9e8180cbf2 GET /v1/drugs/b7cef24c-9bed-4f1e-9f2f-6c9e8180cbf2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "150 mg",
"packaging": "05909990953714 ¦ Rp ¦ 19560\n30 tabl.",
"substance": "Moclobemidum 150 mg",
"common_name": "Moclobemidum",
"pl_product_id": "100109461",
"pozwolenie_nr": "09537",
"auth_procedure": "NAR",
"authorisation_validity": "2024-12-31"
}See everything about moclobemide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.